ACRV vs CVX · $65.1M cap vs P/E 17, rev $118.66B
Acrivon Therapeutics, Inc. Common Stock (ACRV) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Acrivon Therapeutics, Inc. Common Stock (ACRV) is a biotechnology company listed on NASDAQ.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
ACRV does not have a complete income-statement cache yet.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
ACRV currently screens at market cap $65.1M. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the ACRV and CVX stock pages for the full models.
Not investment advice.